(Q34375688)

1 August 2017

1 reference

title

Inhibitors of virus replication: recent developments and prospects (English)

1 reference

1 August 2017

2

Leevi Kääriäinen

1 reference

1 August 2017

3

Tero Ahola

1 reference

1 August 2017

Julia Magden

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 December 2004

1 reference

Applied Microbiology and Biotechnology

1 August 2017

published in

1 reference

1 August 2017

volume

66

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

612-621

1 reference

https://scigraph.springernature.com/pub.10.1007/s00253-004-1783-3

1 August 2017

exact match

0 references

cites work

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00253-004-1783-3

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00253-004-1783-3

The entry of entry inhibitors: a fusion of science and medicine

21 January 2018

1 reference

12 December 2020

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Membrane binding mechanism of an RNA virus-capping enzyme

1 reference

12 December 2020

Three-dimensional structure of poliovirus at 2.9 A resolution.

1 reference

12 December 2020

A target site for template-based design of measles virus entry inhibitors.

1 reference

12 December 2020

Neonatal coxsackie B virus infection-a treatable disease?

1 reference

12 December 2020

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers

1 reference

12 December 2020

'Flu' and structure-based drug design

1 reference

12 December 2020

Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections

1 reference

12 December 2020

Discovery of antivirals against smallpox

1 reference

12 December 2020

Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein

1 reference

12 December 2020

Functions of alphavirus nonstructural proteins in RNA replication

1 reference

12 December 2020

Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak.

1 reference

12 December 2020

Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses

1 reference

12 December 2020

Structure of a human common cold virus and functional relationship to other picornaviruses

1 reference

12 December 2020

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

12 December 2020

Viral RNA replication in association with cellular membranes.

1 reference

12 December 2020

Orally active fusion inhibitor of respiratory syncytial virus

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP.

1 reference

12 December 2020

Antiviral drugs in current clinical use.

1 reference

12 December 2020

Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme

1 reference

12 December 2020

Early administration of oral oseltamivir increases the benefits of influenza treatment

1 reference

12 December 2020

Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives

1 reference

12 December 2020

Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances

1 reference

12 December 2020

In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity

1 reference

12 December 2020

Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule

1 reference

12 December 2020

Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment

1 reference

12 December 2020

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

12 December 2020

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

1 reference

12 December 2020

The treatment of rhinovirus infections: progress and potential

1 reference

12 December 2020

Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates

1 reference

12 December 2020

Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation

1 reference

12 December 2020

Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors

1 reference

12 December 2020

The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.

1 reference

12 December 2020

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

1 reference

12 December 2020

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms

1 reference

12 December 2020

Ribavirin causes error catastrophe during Hantaan virus replication.

1 reference

12 December 2020

Virus-specific mRNA capping enzyme encoded by hepatitis E virus

1 reference

12 December 2020

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

12 December 2020

Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses

1 reference

12 December 2020

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

1 reference

12 December 2020

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

12 December 2020

Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens

1 reference

12 December 2020

Recent advances in the chemistry of parainfluenza-1 (Sendai) virus inhibitors

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

1 reference

12 December 2020

An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization

1 reference

12 December 2020

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements

1 reference

12 December 2020

West Nile virus: a growing concern?

1 reference

12 December 2020

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

12 December 2020

Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design

1 reference

12 December 2020

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor

1 reference

12 December 2020

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

1 reference

12 December 2020

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

1 reference

12 December 2020

Hepatitis C: molecular virology and antiviral targets

1 reference

12 December 2020

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

1 reference

12 December 2020

Hepatitis C therapeutics: current status and emerging strategies

1 reference

12 December 2020

Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors

1 reference

12 December 2020

Dengue: an arthropod-borne disease of global importance

1 reference

12 December 2020

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

1 reference

12 December 2020

Twenty years of therapy for HIV-1 infection.

1 reference

12 December 2020

10.1007/S00253-004-1783-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1027476516

0 references

1 reference